Global Cerebrospinal Fluid (CSF) Management Devices Market 2017-2021
About Cerebrospinal Fluid (CSF) Management Devices
CSF shunts and CSF drainage systems are used to manage or divert the CSF flow in the body away from the ventricles in a controlled manner, thereby providing an alternative pathway. Hydrocephalus is the abnormal accumulation of CSF within the brain cavities called ventricles (space near the spine). It occurs due to an imbalance in the formation and absorption rate of the fluid. This results in ventricle enlargement and increased pressure inside the head.
Technavio’s analysts forecast the global cerebrospinal fluid (CSF) management devices market to grow at a CAGR of 3.95% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global cerebrospinal fluid (CSF) management devices market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Cerebrospinal Fluid (CSF) Management Devices Market 2017-2021
Technavio recognizes the following companies as the key players in the global cerebrospinal fluid (CSF) management devices market: B. Braun, DePuy Synthes, Integra LifeSciences, Medtronic and Sophysa.
Other Prominent Vendors in the market are: BeckerSmith Medical, Biometrix, Dispomedica, Möller Medical and Spiegelberg.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is growing technological advances. The advances in neurosurgical techniques have led hospitals, ASCs, and neurosurgical centers to perform a diverse range of interventional procedures for treating many neurovascular disorders. There have been considerable technological changes in the development of CSF management devices.”
According to the report, one driver in the market is increase in prevalence of neurological disorders. Approximately 12% of deaths worldwide are caused by neurological disorders. Epilepsy, stroke, Alzheimer's disease, angina, multiple sclerosis, neurological infections, tumors, migraine, and traumatic brain injuries are some of the most prevalent conditions affecting brain. According to the CDC, in February 2016, around 1% of the adult population aged 18 or more were suffering from active epilepsy, a condition where patients report a history of seizure for which they take medication.
Further, the report states that one challenges in the market is complications and risks associated with CSF management devices. The use of CSF devices such as shunts and drainage help in managing hydrocephalus. This has some complications such as malfunction, infection, and subdural hematoma. The shunt malfunction is due to complete or partial blockage of the shunt, which causes it to function intermittently or fail. This will result in hydrocephalus not being treated properly. Hydrocephalus is compensated when the CSF production and absorption is balanced and when out of balance, complications such as overdrainage or elevated pressure occur.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- https://www.technavio.com/report/global-cerebrospinal-fluid-csf-management-devices-market-2017-2021
B. Braun, DePuy Synthes, Integra LifeSciences, Medtronic, Sophysa, BeckerSmith Medical, Biometrix, Dispomedica, Möller Medical and Spiegelberg.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook